title: Antibodies to blood stage antigens of Plasmodium falciparum in rural Gambians and their relation to protection against infection.
abstract: Cross-sectional and longitudinal studies were performed in a rural population living in The Gambia to examine the relationship between several in vitro assays of the host immune response to asexual stages of Plasmodium falciparum and protection from malaria in vivo. Assays included an enzyme-linked immunosorbent assay for antibodies to schizont antigens; an indirect immunofluorescence assay for total antiblood-stage antibodies; an immunofluorescence assay on glutaraldehyde-fixed parasites to detect antibodies to antigen Pf 155; an assay for serum inhibition of red blood cell invasion; a micro-agglutination assay to detect antibodies to neo-antigens on the surface of infected red blood cells; and an assay using polymorphonuclear leucocytes to detect antibodies capable of opsonizing schizont infected red blood cells. There were marked differences in the age-related pattern of response for different assays performed on sera obtained at a cross-sectional survey of 280 individuals. Examination of the correlation between the various immune responses and malariometric indices at the population level and at the individual level provided no evidence that any of the in vitro assays were related to protective immunity. The relationship between in vitro measurements of the anti-malarial immune response and protection from clinical episodes of malaria was examined in a group of 134 children aged 11 years and under who were monitored weekly throughout an entire malaria transmission season. The only immune factor to show a consistent protective effect against clinical malaria was the titre of antibodies to neo-antigens on the infected erythrocyte surface (P = 0.01). The same longitudinal techniques were used to examine the effect of two non-immunological factors, sickle cell trait and mosquito net usage, both of which showed significant protection against clinical episodes and malaria.
authors.affiliation: Medical Research Council Laboratories, Gambia, West Africa.
authors.forename: K
authors.initials: K
authors.lastname: Marsh
authors.forename: L
authors.initials: L
authors.lastname: Otoo
authors.forename: R J
authors.initials: RJ
authors.lastname: Hayes
authors.forename: D C
authors.initials: DC
authors.lastname: Carson
authors.forename: B M
authors.initials: BM
authors.lastname: Greenwood
mesh_terms: D000367:Age Factors; D000818:Animals; D000913:Antibodies, Protozoan / Q000032:analysis*; D000953:Antigens, Protozoan / Q000276:immunology*; D002648:Child; D002675:Child, Preschool; D003430:Cross-Sectional Studies; D004910:Erythrocyte Membrane / Q000276:immunology; D005714:Gambia; D006801:Humans; D007110:Immunity, Active; D007113:Immunity, Innate; D007223:Infant; D008137:Longitudinal Studies; D008288:Malaria / Q000276:immunology* / Q000517:prevention & control; D010963:Plasmodium falciparum / Q000276:immunology*; D012424:Rural Population; D012805:Sickle Cell Trait
chemical_list: D000913:Antibodies, Protozoan; D000953:Antigens, Protozoan